EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells

Riley M Horvath, Zabrina L Brumme iD, Ivan Sadowski iD

Journal of Virology · 2023

DOI: 10.1128/jvi.00923-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2023. Verfasst von Riley M Horvath und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Molecular Epigenetics Group, LSI, University of British Columbia , Vancouver, British Columbia, Can…. Hauptthemen laut MEDLINE: HIV-1, Virus Latency, Virus Activation, Proviruses. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gouvernement du Canada | Canadian Institutes of Health Research (IRSC), Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Michael Smith Health Research BC (MSFHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Latent HIV-1 provirus represents the barrier toward a cure for infection and is dependent upon the host RNA Polymerase (Pol) II machinery for reemergence. Here, we find that inhibitors of the RNA Pol II mediator kinases CDK8/19, Senexin A and BRD6989, inhibit induction of HIV-1 expression in response to latency-reversing agents and T cell signaling agonists. These inhibitors were found to impair recruitment of RNA Pol II to the HIV-1 LTR. Furthermore, HIV-1 expression in response to several latency reversal agents was impaired upon disruption of CDK8 by shRNA or gene knockout. However, the effects of CDK8 depletion did not entirely mimic CDK8/19 kinase inhibition suggesting that the mediator kinases are not functionally redundant. Additionally, treatment of CD4 + peripheral blood mononuclear cells isolated from people living with HIV-1 and who are receiving antiretroviral therapy with Senexin A inhibited induction of viral replication in response to T cell stimulation by PMA and ionomycin. These observations indicate that the mediator kinases, CDK8 and CDK19, play a significant role for regulation of HIV-1 transcription and that small molecule inhibitors of these enzymes may contribute to therapies designed to promote deep latency involving the durable suppression of provirus expression. IMPORTANCE A cure for HIV-1 infection will require novel therapies that can force elimination of cells that contain copies of the virus genome inserted into the cell chromosome, but which is shut off, or silenced. These are known as latently-infected cells, which represent the main reason why current treatment for HIV/AIDS cannot cure the infection because the virus in these cells is unaffected by current drugs. Our results indicate that chemical inhibitors of Cdk8 also inhibit the expression of latent HIV provirus. Cdk8 is an important enzyme that regulates the expression of genes in response to signals to which cells need to respond and which is produced by a gene that is frequently mutated in cancers. Our observations indicate that Cdk8 inhibitors may be employed in novel therapies to prevent expression from latent provirus, which might eventually enable infected individuals to cease treatment with antiretroviral drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Virus LatencyVirus ActivationProvirusesCyclin-Dependent Kinase 8HIV InfectionsProtein Kinase InhibitorsT-LymphocytesHumansCD4-Positive T-LymphocytesVirus ReplicationCyclin-Dependent KinasesRNA Polymerase II

Stichwörter der Autor:innen

BRD6989CDK19CDK8HIV-1LTRSenexin AT cell signalingblock and lockinhibitorslatencymediator kinasetranscription

Substanzen

Cyclin-Dependent Kinase 8CDK8 protein, humanCDK19 protein, humanProtein Kinase InhibitorsCyclin-Dependent KinasesRNA Polymerase II

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Molecular Epigenetics Group, LSI, University of British Columbia , Vancouver, British Columbia, Canada.
  • Faculty of Health Sciences, Simon Fraser University , Burnaby, British Columbia, Canada.
  • British Columbia Centre for Excellence in HIV/AIDS , Vancouver, British Columbia, Canada.

ORCID-Profile: Zabrina L Brumme, Ivan Sadowski

Förderung

  • Gouvernement du Canada | Canadian Institutes of Health Research (IRSC)
  • Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)
  • Michael Smith Health Research BC (MSFHR)

Zitieren

APA

Horvath, R. M., Brumme, Z. L., & Sadowski, I. (2023). CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells. Journal of Virology. https://doi.org/10.1128/jvi.00923-23

Vancouver

Horvath RM, Brumme ZL, Sadowski I. CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells. Journal of Virology. 2023. doi:10.1128/jvi.00923-23

BibTeX
@article{Horvath2023,
  author = {Horvath, Riley M and Brumme, Zabrina L and Sadowski, Ivan},
  title = {CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells},
  journal = {Journal of Virology},
  year = {2023},
  doi = {10.1128/jvi.00923-23}
}
Kostenlos starten →